Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 1/20 | 0.55 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.54 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.54 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.54 |
| ▸ | RUNX1 | Q01196 | 1/20 | 0.54 |
| ▸ | CBFB | Q13951 | 1/20 | 0.54 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.51 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.48 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9172845 | 0.98 | ROCK2 (0.54) | ROCK2ROCK1KDM4EKMT2AMAPT | |
| SCHEMBL11307021 | 0.87 | KDM4E (0.51) | ROCK2ROCK1KDM4EKMT2AMAPT | |
| SCHEMBL1248942 | 0.86 | CD40 (0.53) | ROCK2ROCK1KDM4EKMT2AMAPT | |
| SCHEMBL8761617 | 0.85 | BAZ1A (0.51) | ROCK2ROCK1KDM4EKMT2AMAPT | |
| SCHEMBL1156215 | 0.84 | PEPD (0.42) | ROCK2ROCK1KMT2AMAPTMEN1 | |
| SCHEMBL26885093 | 0.83 | ALDH1A1 (0.48) | KDM4EKMT2AMAPTMEN1NPC1 | |
| SCHEMBL14360693 | 0.83 | CA2 (0.46) | ROCK2ROCK1KDM4EKMT2AMAPT | |
| SCHEMBL2704274 | 0.81 | ALDH1A1 (0.50) | KDM4EKMT2AMAPTMEN1NPC1 | |
| SCHEMBL10949559 | 0.80 | MAP2K7 (0.45) | — | |
| SCHEMBL3734462 | 0.80 | SMN1; SMN2 (0.46) | KMT2AMAPTMEN1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102037157-B | Adhesion promotion of metal to laminate with a multi-functional compound | ENTHONE | 2014-05-28 | — | — | CN | claimed |
| CN-102037157-A | Adhesion promotion of metal to laminate with a multi-functional compound | ENTHONE | 2011-04-27 | — | — | CN | claimed |
| CN-119702079-A | Preparation method of composite material for cooperatively treating unsymmetrical dimethylhydrazine sewage by ozone photocatalysis | 北方工业大学 | 2025-03-28 | — | — | CN | disclosed |
| US-8519074-B2 | Comb polymers for supramolecular nanoconfinement | The University of Massachusettes (US) | 2013-08-27 | — | — | US | disclosed |
| US-20110178190-A1 | COMB POLYMERS FOR SUPRAMOLECULAR NANOCONFINEMENT | NATIONAL SCIENCE FOUNDATION | 2011-07-21 | — | — | US | disclosed |
| US-7879893-B2 | Zinc binding ligand; sustained release of insulin | NOVO NORDISK A/S (DK) | 2011-02-01 | — | — | US | disclosed |
| US-7879893-B2 | Zinc binding ligand; sustained release of insulin | NOVO NORDISK A/S (DK) | 2011-02-01 | — | — | US | disclosed |
| US-7879893-B2 | Zinc binding ligand; sustained release of insulin | NOVO NORDISK A/S (DK) | 2011-02-01 | — | — | US | disclosed |
| US-20090123563-A1 | Pharmaceutical Preparations Comprising Insulin, Zinc Ions and Zinc-Binding Ligand | NOVO NORDISK A/S (DK) | 2009-05-14 | — | — | US | disclosed |
| US-20090123563-A1 | Pharmaceutical Preparations Comprising Insulin, Zinc Ions and Zinc-Binding Ligand | NOVO NORDISK A/S (DK) | 2009-05-14 | — | — | US | disclosed |
| US-20090123563-A1 | Pharmaceutical Preparations Comprising Insulin, Zinc Ions and Zinc-Binding Ligand | NOVO NORDISK A/S (DK) | 2009-05-14 | — | — | US | disclosed |
| US-4840887-A | USEFUL GROUP RELEASED BY CLEAVAGE BETWEEN SULFONYL GROUP AND A NITROGEN, SULFUR OR OXYGEN ATOM; STABILITY | FUJI PHOTO FILM CO., LTD. (JP) | 1989-06-20 | — | — | US | disclosed |
| US-4820622-A | RELEASING DIFFUSIBLE DYE IN ALKALINE SYSTEM AFTER HALIDE REDUCTION | FUJI PHOTO FILM CO., LTD. (JP) | 1989-04-11 | — | — | US | disclosed |
| US-4783396-A | Silver halide photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1988-11-08 | — | — | US | disclosed |
| US-4770990-A | Silver halide photographic light-sensitive material containing a compound capable of imagewise releasing a photographically useful group during development | FUJI PHOTO FILM CO., LTD. (JP) | 1988-09-13 | — | — | US | disclosed |
| US-4740453-A | Silver halide photosensitive material containing a compound capable of releasing a photographically useful group | FUJI PHOTO FILM CO., LTD. (JP) | 1988-04-26 | — | — | US | disclosed |
| EP-0220746-A2 | Silver halide photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1987-05-06 | — | — | EP | disclosed |
| US-4649096-A | EXPOSURE, DEVELOPMENT, ALKALI HYDROXIDE, ALKANOLAMINE, SULFITE, THIOSULFATE, P-DIHYDROXYBENZENE | MITSUBISHI PAPER MILLS, LTD. (JP) | 1987-03-10 | — | — | US | disclosed |
| US-4636456-A | EXPOSURE, SILVER HALIDE EMULSIONS, HYDROQUINONE OR ESTER OR CARBONATE, DEVELOPMENT INHIBITORS | FUJI PHOTO FILM CO., LTD. (JP) | 1987-01-13 | — | — | US | disclosed |
| EP-0198438-A2 | Silver halide photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1986-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090123563-A1 | Pharmaceutical Preparations Comprising Insulin, Zinc Ions and Zinc-Binding Ligand | IAPP, IRS1, HBB | ROCK2 4807/4885ROCK1 4676/4885KDM4E 4599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.